Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

View:
Post by okgonow on Oct 20, 2023 3:31pm

FYI

Date Issuer Insider Transaction Amount New Balance
Recent filings 
Filed 2023-10-20 14:17
 
Tx date 2023-10-19
$LABS
MediPharm Labs Corp.
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+1,655,172 vol
11,066,242  
Filed 2023-10-20 14:16
 
Tx date 2023-10-19
$LABS
MediPharm Labs Corp.
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Stock Units
57 - Exercise of rights

-1,655,172 vol
4,890,508  
Older filings 
Comment by TreborTheGreat on Oct 20, 2023 5:03pm
Looks like he is increasing his position to now 11MM Shares. Owns about 3% of the Company outright.  
Comment by Redwine12345 on Oct 23, 2023 2:22pm
When insiders convert warrants and rights to shares, it is a strong message to public that they are willing to take actual risk by owing common shares from no risk owing rights or warrants.  The writing is on the wall. Be patient my friends. This time we are in the right boat. :)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities